http://rdf.ncbi.nlm.nih.gov/pubchem/reference/25566422

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage 176
issn 0969-9961
issueIdentifier 1
pageRange 169-176
publicationName Neurobiology of Disease
startingPage 169
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_af60feca798ba7542b39de7d55c32044
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e84350a65e9a47198640404e26ee8ec4
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_2ea80026665e031b7380448129ca3b62
bibliographicCitation Silva IR, Nehlig A, Rosim FE, Vignoli T, Persike DS, Ferrandon A, Sinigaglia-Coimbra R, Fernandes MJ. The A1 receptor agonist R-Pia reduces the imbalance between cerebral glucose metabolism and blood flow during status epilepticus: could this mechanism be involved with neuroprotection? Neurobiol Dis. 2011 Jan;41(1):169–76. doi: 10.1016/j.nbd.2010.09.004. PMID: 20850530.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9d476494f76d953d9d55341f54042f3a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5e6176433dfd9d21ee622a989c3b2a0e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a0407b1bf0ad5dcb5b0b1f096b8f7a35
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f67487317016d4ec59e20edbd88bfd96
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a735145100c5c5586353d4aacb6967d8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bd6bd7d622ce3625a3160ba74e753c3b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a2c4d8ae8aa5f273104c259918e2a535
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7b03ece71422e109136114471758d5c3
date 201101
identifier https://doi.org/10.1016/j.nbd.2010.09.004
https://pubmed.ncbi.nlm.nih.gov/20850530
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/20475
https://portal.issn.org/resource/ISSN/0969-9961
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title The A1 receptor agonist R-Pia reduces the imbalance between cerebral glucose metabolism and blood flow during status epilepticus: Could this mechanism be involved with neuroprotection?
discusses http://id.nlm.nih.gov/mesh/M0000377
http://id.nlm.nih.gov/mesh/M0028008
http://id.nlm.nih.gov/mesh/M0545333
http://id.nlm.nih.gov/mesh/M0009339
http://id.nlm.nih.gov/mesh/M0136524
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D013226Q000473
http://id.nlm.nih.gov/mesh/D013226Q000188
http://id.nlm.nih.gov/mesh/D058907Q000494
http://id.nlm.nih.gov/mesh/D005947Q000378
http://id.nlm.nih.gov/mesh/D002560Q000187
http://id.nlm.nih.gov/mesh/D000241Q000031
http://id.nlm.nih.gov/mesh/D009474Q000378
http://id.nlm.nih.gov/mesh/D018696Q000494
hasSubjectTerm http://id.nlm.nih.gov/mesh/D013226Q000378
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D051381
http://id.nlm.nih.gov/mesh/D009474Q000187
http://id.nlm.nih.gov/mesh/D000241Q000494
http://id.nlm.nih.gov/mesh/D002560Q000502
http://id.nlm.nih.gov/mesh/D009474Q000473
http://id.nlm.nih.gov/mesh/D017208
http://id.nlm.nih.gov/mesh/D000818
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8636
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9299
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9191
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439268
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5910
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5909
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128814610
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129133541
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129621433
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID246907358
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129002180

Total number of triples: 62.